Senseonics (NASDAQ:SENS) will release its earnings data after the market closes on Wednesday, August 7th. Analysts expect Senseonics to post earnings of ($0.16) per share for the quarter.
Senseonics (NASDAQ:SENS) last posted its quarterly earnings results on Thursday, May 9th. The company reported ($0.17) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.05). The company had revenue of $3.42 million during the quarter, compared to analyst estimates of $4.05 million.
SENS stock opened at $1.08 on Tuesday. The company has a 50-day moving average of $1.60. Senseonics has a 52 week low of $1.02 and a 52 week high of $4.89.
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
See Also: Day Trading
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.